Mid-Illinois Hem/Onc Asoc — Normal, Illinois

Mid-Illinois Hem/Onc Asoc is a clinical research site located in Normal, Illinois, United States 61761.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Mid-Illinois Hem/Onc Asoc has participated in 1 clinical trials.

Therapeutic areas: Chronic Myeloid Leukemia.

Sponsors: Bristol-Myers Squibb.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Normal

Browse all research sites in Illinois · View every site in Normal

• Advocate Health and Hospitals Corp
• Bromenn Regional Medical Center
• Community Cancer Center
• Carle Cancer Institute Normal
• Illinois CancerCare-Community Cancer Center
• Carle BroMenn Medical Center
• Community Cancer Center Foundation
• Sneeze, Wheeze & Itch Associates
• Sneeze Wheeze and Itch Associates
• Research Site
• GSK Investigational Site
• Midwest Allergy Sinus Asthma SC

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mid-Illinois Hem/Onc Asoc?

Mid-Illinois Hem/Onc Asoc has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mid-Illinois Hem/Onc Asoc conducted?

Mid-Illinois Hem/Onc Asoc has 1 clinical trials on record. Their work covers Chronic Myeloid Leukemia.

Is Mid-Illinois Hem/Onc Asoc accredited by Crixeo Clinical Trials?

Mid-Illinois Hem/Onc Asoc has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mid-Illinois Hem/Onc Asoc?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.